Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Poland Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20062
20072
20081
20093
20102
20111
20122
20133
20142
20155
20162
20173
20193
20222
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated4
Recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Eli Lilly and Company8
Sanofi4
Mannkind Corporation3
Boehringer Ingelheim2
Gan and Lee Pharmaceuticals, USA2
Lexicon Pharmaceuticals2
Andromeda Biotech Ltd.1
AstraZeneca1
Diamyd Medical AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 140
Diabetes Mellitus19
Diabetes Mellitus, Type 23
Insulin Resistance2
Asthma1
Autoimmune Diseases1
Cardiovascular Diseases1
Chronic Limb-Threatening Ischemia1
Immune System Diseases1
Metabolic Diseases1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.